ABT vs LH · P/E 25, rev $44.33B vs P/E 23, rev $7.27B
Abbott Laboratories (ABT) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported LH revenue for 2026-06-30 was $7.27B. Net income was $576.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the ABT and LH stock pages for the full models.
Not investment advice.